clinical trial · NCT04697381
Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS
Pfizer·phase3·completed·n = 33
Prader-Willi Syndromesomatropin - GH naïve pediatric cohortsomatropin - GH treated cohortsomatropin - adult cohort
brief summary
This is a multicenter, open label, multi cohort study to evaluate the efficacy and safety of somatropin in a cohort of Japanese participants with PWS.
started
Feb 9, 2021
primary completion
Dec 6, 2022
completion
Apr 15, 2024
last updated
Jan 14, 2026
official title
A PHASE 3 MULTICENTER, OPEN LABEL, MULTI COHORT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SOMATROPIN IN JAPANESE PARTICIPANTS WITH PRADER-WILLI SYNDROME (PWS)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol